What is the recommended usage and dosage of Selinisol Tablets?
Selinexor (Selinexor) is a selective nuclear export inhibitor (SINE drugs), mainly used to treat malignant tumors such as multiple myeloma and diffuse large B cell lymphoma (DLBCL). When using selinesol tablets, correct usage and dosage are crucial to ensure efficacy and reduce adverse reactions. Generally, selinesol should be used under the guidance of an experienced oncologist and individually adjusted based on the patient's specific condition and treatment plan.
Selinisole is often given in combination with dexamethasone in the treatment of multiple myeloma. The recommended dosage is 80 mg of selinexol and 20 mg of dexamethasone, taken twice a week on alternate days. The standard recommended dose of selinesol for the treatment of patients with diffuse large B-cell lymphoma is 60 mg once weekly. Patients should take the medicine after eating and drink it with enough water to avoid taking medicine on an empty stomach to reduce the occurrence of gastrointestinal adverse reactions.

During treatment, patients need to pay close attention to their tolerance. If serious side effects occur, such as nausea, vomiting, fatigue, loss of appetite, hyponatremia, etc., the doctor may adjust the dose, delay the administration time, or even temporarily discontinue the drug according to the specific situation. To reduce the risk of adverse reactions, supportive care is usually recommended during treatment, such as antiemetics, fluid rehydration, and nutritional support. In addition, regular monitoring of hematological indicators, electrolyte levels, and liver and kidney functions are also important measures to ensure safe medication use.
It is important to note that the use of selinesol tablets should strictly follow the doctor's instructions, and the dosage or frequency should not be changed at will. If the patient misses a dose, he should take it as soon as possible; if it is close to the time of the next dose, he should skip the missed dose and should not take a double dose at one time. During the entire treatment period, patients should actively communicate with their doctors about any discomfort symptoms and promptly adjust treatment strategies to maximize the anti-tumor effect of selinesol while reducing unnecessary side effects.
Reference materials:https://www.selincro.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)